一、基本情况
| 姓名 | 性别 | 出生年月 |
招生专业 |
| ||
| 王长利 | 男 | 195707 | ||||
| 专业技术职务 | 行政职务 | |||||
|
主任医师，教授 |
科主任 |
肿瘤学 | ||||
|
招生类型 |
所在单位 | |||||
| 科学学位（博）\科学学位（硕）\专业学位（博）\专业学位（硕） | 天津医科大学 肿瘤医院 | |||||
| 最后学历及学位 | ||||||
| 毕业院校 | 毕业时间 | 所学专业 | 所获学位 | |||
| 天津医科大学 | 2012 年 | 肿瘤学 | 博士 | |||
| | 科学研究主要方向 | |||||
|
wangchangli@medmail. com.cn |
1、肺癌诊疗相关分子标志物研究 2、肺癌的精准治疗 | |||||
二、目前承担科研课题情况
| 项目名称（级别最高 3-5 项） | 项目来源 | 本人排名 | 本人可支配 经费（万） | 项目起止时间 |
| 1 SDH5 蛋白在 EGFR-TKI 治疗突变 型肺腺癌患者原发性耐药中的作用 |
国家自然科学基金 |
1 |
30 |
201501-20161 2 |
| 2 肺癌分子预测模型的建立及在个体 化和综合治疗中的应用 |
天津市科委抗癌重大专项 |
1 |
50 |
201210-20150 9 |
三、发表论文论著情况
| 题目 | 刊物或出版社 | 本人排名 | 发表时间 | 收录情况 （SCI、EI） |
| Succinate dehydrogenase 5 (SDH5) regulates glycogen synthase kinase 3β-β-catenin-mediated lung cancer metastasis | J Biol Chem | 通讯作者 | 2013 | SCI |
| Osteopontin Combined With CD44v6. a Novel Prognostic Biomarker in Non-Small Cell Lung Cancer Undergoing Curative Resection | Ann Thorac Surg | 通讯作者 | 2013 | SCI |
| Functional MUC4 suppress epithelial-mesenchymal transition in lung adenocarcinoma metastasis | Tumour Biol | 通讯作者 | 2014 | SCI |
| Clinical significance of E-cadherin, β-catenin, vimentin and S100A4 expression in completely resected squamous cell lung carcinoma | J Clin Pathol. | 通讯作者 | 2013 | SCI |
| Current evidences on IL1B polymorphisms and lung cancer susceptibility: a meta-analysis | Tumour Biol | 通讯作者 | 2013 | SCI |
| Assessing the nutritional status of elderly Chinese lung cancer patients using the Mini-Nutritional Assessment tool | Clin Interv Aging | 通讯作者 | 2013 | SCI |
| The effect of the extent of lymph node dissection for stage IA non-small-cell lung cancer on patient disease-free survival | Clin Lung Cancer | 通讯作者 | 2013 | SCI |
| Factors that affect sleep quality: perceptions made by patients in the intensive care unit after thoracic surgery | Support Care Cancer. | 通讯作者 | 2013 | SCI |
| Prognostic value analysis of mutational and clinicopathological factors in non-small cell lung cancer | PLoS One | 通讯作者 | 2014 | SCI |
| Survival analysis of patients with non-small cell lung cancer who underwent surgical resection following 4 lung cancer resection guidelines |
BMC Cancer. | 通讯作者 | 2014 | SCI |
| Positive expression of pro-opiomelanocortin (POMC) is a novel independent poor prognostic marker in surgically resected non-small cell lung cancer | Tumor Biol | 通讯作者 | 2015 | SCI |
| Validation of EORTC QLQ-LC43 for Chinese patients with lung cancer | Lung Cancer | 通讯作者 | 2014 | SCI |
| Cross-cultural verification of the EORTC QLQ-C15-PAL questionnaire in mainland China | Palliat Med | 通讯作者 | 2015 | SCI |
| Clinical significance of preoperative neutrophil-lymphocyte vs platelet-lymphocyte ratio in primary operable patients with non-small cell lung cancer |
Am J Surg | 通讯作者 |
2015 | SCI |
| Prognostic Significance of Combination of Preoperative Platelet Count and Neutrophil-Lymphocyte Ratio (COP-NLR) in Patients with Non-Small Cell Lung Cancer: Based on a Large Cohort Study |
PLoS One | 通讯作者 |
2015 | SCI |
| Validation of EORTC IN-PATSAT32 for Chinese cancer patients | Support Care Cancer | 通讯作者 | 2015 | SCI |
四、主要业绩
